SAN DIEGO, March 29, 2016 /PRNewswire/ -- Shareholder Rights Law Firm Johnson & Weaver, LLP is investigating potential violations of the federal securities laws by Trovagene, Inc. (NASDAQ: TROV). Trovagene a molecular diagnostic company focuses on the development and commercialization of proprietary urine-based cell-free molecular diagnostic technology for use in disease detection and monitoring across various medical disciplines.
On March 28, 2016 it was announced that the Trovagene Board of Directors terminated the employment of CEO Antonius Schuh and CFO Stephen Zaniboni and has filed a complaint against both. The complaint alleges that Dr. Schuh and Mr. Zaniboni failed to present a lucrative corporate opportunity to Trovagene and instead took that prospect for their own personal benefit. On the news, Trovagene's shares fell as much as 40 percent in pre-market trading on March 29, 2016.
If you are a Trovagene shareholder and are interested in learning more about the investigation or your legal rights and remedies, please contact Jim Baker (email@example.com) at 619-814-4471. If you email, please include your phone number.
Johnson & Weaver, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonandweaver.com. Attorney advertising. Past results do not guarantee future outcomes.
Johnson & Weaver, LLP
Jim Baker, 619-814-4471
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/trovagene-shareholder-trov-alert-shareholder-rights-law-firm-johnson--weaver-llp-announces-investigation-of-trovagene-inc-encourages-investors-to-contact-the-firm-300242519.html
SOURCE Johnson & Weaver, LLP